Engineering human pluripotent stem cell lines to evade xenogeneic transplantation barriers is a research paper published in Stem Cell Reports (2024). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Bill and Melinda Gates Foundation
Grant: OPP1206188
National Institutes of Health
Grant: R21AI132910
Juvenile Diabetes Research Foundation
Grant: 2-SRA-2017-365-S-B
New York Stem Cell Foundation
Grant: NYSCF-RI14
NCI NIH HHS
Grant: P50 CA171963
NCI NIH HHS
Grant: R01 CA205239
NCI NIH HHS
Grant: P30 CA023074
NCI NIH HHS
Grant: P30 CA091842
National Institutes of Health
Grant: 5R01CA205239-02
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY
National Institutes of Health
Grant: 5R21AI132910-02
PLURIPOTENT STEM CELL-BASED IMMUNOTHERAPIES
National Institutes of Health
Grant: 5P50CA171963-09
Specialized Program Of Research Excellence (SPORE) in Leukemia.
Juvenile Diabetes Research Foundation United States of America
FWCI
4.00
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords